These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 17410186
1. CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment. Juarez J, Dela Pena A, Baraz R, Hewson J, Khoo M, Cisterne A, Fricker S, Fujii N, Bradstock KF, Bendall LJ. Leukemia; 2007 Jun; 21(6):1249-57. PubMed ID: 17410186 [Abstract] [Full Text] [Related]
2. Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro. Juarez J, Bradstock KF, Gottlieb DJ, Bendall LJ. Leukemia; 2003 Jul; 17(7):1294-300. PubMed ID: 12835717 [Abstract] [Full Text] [Related]
3. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood. Dialynas DP, Shao L, Billman GF, Yu J. Stem Cells; 2001 Jul; 19(5):443-52. PubMed ID: 11553853 [Abstract] [Full Text] [Related]
4. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways. Scupoli MT, Donadelli M, Cioffi F, Rossi M, Perbellini O, Malpeli G, Corbioli S, Vinante F, Krampera M, Palmieri M, Scarpa A, Ariola C, Foà R, Pizzolo G. Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253 [Abstract] [Full Text] [Related]
5. Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia. van den Berk LC, van der Veer A, Willemse ME, Theeuwes MJ, Luijendijk MW, Tong WH, van der Sluis IM, Pieters R, den Boer ML. Br J Haematol; 2014 Jul; 166(2):240-9. PubMed ID: 24697337 [Abstract] [Full Text] [Related]
6. Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow. Ratajczak MZ, Kucia M, Reca R, Majka M, Janowska-Wieczorek A, Ratajczak J. Leukemia; 2004 Jan; 18(1):29-40. PubMed ID: 14586476 [Abstract] [Full Text] [Related]
7. The involvement of stromal derived factor 1alpha in homing and progression of multiple myeloma in the 5TMM model. Menu E, Asosingh K, Indraccolo S, De Raeve H, Van Riet I, Van Valckenborgh E, Vande Broek I, Fujii N, Tamamura H, Van Camp B, Vanderkerken K. Haematologica; 2006 May; 91(5):605-12. PubMed ID: 16627256 [Abstract] [Full Text] [Related]
8. Focal adhesion kinase is required for CXCL12-induced chemotactic and pro-adhesive responses in hematopoietic precursor cells. Glodek AM, Le Y, Dykxhoorn DM, Park SY, Mostoslavsky G, Mulligan R, Lieberman J, Beggs HE, Honczarenko M, Silberstein LE. Leukemia; 2007 Aug; 21(8):1723-32. PubMed ID: 17568820 [Abstract] [Full Text] [Related]
9. Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia? Tavor S, Petit I. Semin Cancer Biol; 2010 Jun; 20(3):178-85. PubMed ID: 20637871 [Abstract] [Full Text] [Related]
10. Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. Burger M, Hartmann T, Krome M, Rawluk J, Tamamura H, Fujii N, Kipps TJ, Burger JA. Blood; 2005 Sep 01; 106(5):1824-30. PubMed ID: 15905192 [Abstract] [Full Text] [Related]
11. Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid mice. Kamel-Reid S, Dick JE, Greaves A, Murdoch B, Doedens M, Grunberger T, Thorner P, Freedman MH, Phillips RA, Letarte M. Leukemia; 1992 Jan 01; 6(1):8-17. PubMed ID: 1531243 [Abstract] [Full Text] [Related]
12. POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL. Sison EA, Magoon D, Li L, Annesley CE, Romagnoli B, Douglas GJ, Tuffin G, Zimmermann J, Brown P. Oncotarget; 2015 Oct 13; 6(31):30902-18. PubMed ID: 26360610 [Abstract] [Full Text] [Related]
13. High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia. Crazzolara R, Kreczy A, Mann G, Heitger A, Eibl G, Fink FM, Möhle R, Meister B. Br J Haematol; 2001 Dec 13; 115(3):545-53. PubMed ID: 11736934 [Abstract] [Full Text] [Related]
14. [Expression of SDF-1alpha and its receptor CXCR4 in acute leukemias and their relationship with extramedullary infiltration]. Liu ZR, Sun H, Zou P. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb 13; 14(1):1-5. PubMed ID: 16584580 [Abstract] [Full Text] [Related]
15. Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B-cell acute lymphoblastic leukaemia. Randhawa S, Cho BS, Ghosh D, Sivina M, Koehrer S, Müschen M, Peled A, Davis RE, Konopleva M, Burger JA. Br J Haematol; 2016 Aug 13; 174(3):425-36. PubMed ID: 27071778 [Abstract] [Full Text] [Related]
16. Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition. Sison EA, Magoon D, Li L, Annesley CE, Rau RE, Small D, Brown P. Oncotarget; 2014 Oct 15; 5(19):8947-58. PubMed ID: 25333254 [Abstract] [Full Text] [Related]
17. Dynamic chemotherapy-induced upregulation of CXCR4 expression: a mechanism of therapeutic resistance in pediatric AML. Sison EA, McIntyre E, Magoon D, Brown P. Mol Cancer Res; 2013 Sep 15; 11(9):1004-16. PubMed ID: 23754844 [Abstract] [Full Text] [Related]
18. Defective p38 mitogen-activated protein kinase signaling impairs chemotaxic but not proliferative responses to stromal-derived factor-1alpha in acute lymphoblastic leukemia. Bendall LJ, Baraz R, Juarez J, Shen W, Bradstock KF. Cancer Res; 2005 Apr 15; 65(8):3290-8. PubMed ID: 15833862 [Abstract] [Full Text] [Related]